Literature DB >> 16699824

Substrate specificity of the amino acid transporter PAT1.

L Metzner1, K Neubert, M Brandsch.   

Abstract

The proton coupled amino acid transporter PAT1 expressed in intestine, brain, and other organs accepts L- and D-proline, glycine, and L-alanine but also pharmaceutically active amino acid derivatives such as 3-amino-1-propanesulfonic acid, L-azetidine-2-carboxylic acid, and cis-4-hydroxy-D-proline as substrates. We systematically analyzed the structural requirements for PAT1 substrates by testing 87 amino acids, proline homologs, indoles, and derivatives. Affinity data and effects on membrane potential were determined using Caco-2 cells. For aliphatic amino acids, a blocked carboxyl group, the distance between amino and carboxyl group, and the position of the hydroxyl group are affinity limiting factors. Methylation of the amino group enhances substrate affinity. Hetero atoms in the proline template are well tolerated. Aromatic alpha-amino acids display low affinity. PAT1 interacts strongly with heterocyclic aromatic acids containing an indole scaffold. The structural requirements of PAT1 substrates elucidated in this study will be useful for the development of prodrugs.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16699824     DOI: 10.1007/s00726-005-0314-6

Source DB:  PubMed          Journal:  Amino Acids        ISSN: 0939-4451            Impact factor:   3.520


  13 in total

1.  The Nitric Oxide Prodrug V-PROLI/NO Inhibits Cellular Uptake of Proline.

Authors:  Sam Y Hong; Gregory L Borchert; Anna E Maciag; Rahul S Nandurdikar; Joseph E Saavedra; Larry K Keefer; James M Phang; Harinath Chakrapani
Journal:  ACS Med Chem Lett       Date:  2010-11-11       Impact factor: 4.345

2.  SLC36A4 (hPAT4) is a high affinity amino acid transporter when expressed in Xenopus laevis oocytes.

Authors:  Samyuktha Muralidharan Pillai; David Meredith
Journal:  J Biol Chem       Date:  2010-11-19       Impact factor: 5.157

Review 3.  The SLC36 family of proton-coupled amino acid transporters and their potential role in drug transport.

Authors:  David T Thwaites; Catriona M H Anderson
Journal:  Br J Pharmacol       Date:  2011-12       Impact factor: 8.739

4.  Transport of the photodynamic therapy agent 5-aminolevulinic acid by distinct H+-coupled nutrient carriers coexpressed in the small intestine.

Authors:  Catriona M H Anderson; Mark Jevons; Muthusamy Thangaraju; Noel Edwards; Nichola J Conlon; Steven Woods; Vadivel Ganapathy; David T Thwaites
Journal:  J Pharmacol Exp Ther       Date:  2009-09-29       Impact factor: 4.030

Review 5.  Nutrient signaling to mTOR and cell growth.

Authors:  Jenna L Jewell; Kun-Liang Guan
Journal:  Trends Biochem Sci       Date:  2013-03-01       Impact factor: 13.807

Review 6.  Intracellular amino acid sensing and mTORC1-regulated growth: new ways to block an old target?

Authors:  Deborah C I Goberdhan
Journal:  Curr Opin Investig Drugs       Date:  2010-12

7.  Amino acid derivatives are substrates or non-transported inhibitors of the amino acid transporter PAT2 (slc36a2).

Authors:  Noel Edwards; Catriona M H Anderson; Kelly M Gatfield; Mark P Jevons; Vadivel Ganapathy; David T Thwaites
Journal:  Biochim Biophys Acta       Date:  2010-08-04

8.  Intestinal absorption of the antiepileptic drug substance vigabatrin is altered by infant formula in vitro and in vivo.

Authors:  Martha Kampp Nøhr; Zia I Thale; Birger Brodin; Steen H Hansen; René Holm; Carsten Uhd Nielsen
Journal:  Pharmacol Res Perspect       Date:  2014-03-24

9.  In Vitro Fertilisation of Mouse Oocytes in L-Proline and L-Pipecolic Acid Improves Subsequent Development.

Authors:  Tamara Treleaven; Madeleine L M Hardy; Michelle Guttman-Jones; Michael B Morris; Margot L Day
Journal:  Cells       Date:  2021-05-29       Impact factor: 6.600

10.  Systemic muscle wasting and coordinated tumour response drive tumourigenesis.

Authors:  Holly Newton; Yi-Fang Wang; Laura Camplese; Joao B Mokochinski; Holger B Kramer; André E X Brown; Louise Fets; Susumu Hirabayashi
Journal:  Nat Commun       Date:  2020-09-16       Impact factor: 14.919

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.